Investors / filer profile

Samaha Eli

active in 2 companies · 1 of 1 positions beat the S&P ~6mo later

Pro
Bought: Pro
Sold: 12
Filings: 2
Companies: 2026-07-07
Last filed

EDGAR · CIK 0001877589 ↗

Track record

How each disclosed position did against the S&P ~6 months later

The outcome curve and every position's resultPro →

+28.6%

median move per position

+12.2%

S&P 500 median, same spans

1 of 1

beat the S&P ~6mo later

Disclosed positions

Estimated from their latest filings — positions may have changed since

Estimated positions from their latest filingsPro →

Activity

Open-market buy & sell volume

BuySell

Total +$2.88M bought · −$5.91M sold

All filings on record

Every Form 4 transaction we track for this filer


TBPHTheravance Biopharma, Inc.	Sell $95.5K · 5,564 sh	2026-07-07	—
TBPHTheravance Biopharma, Inc.	Sell $23.9K · 1,400 sh	2026-07-06	—
TBPHTheravance Biopharma, Inc.	Sell $642.6K · 37,799 sh	2026-07-01	—
TBPHTheravance Biopharma, Inc.	Sell $428.8K · 25,027 sh	2026-06-30	—
TBPHTheravance Biopharma, Inc.	Sell $4.72M · 273,871 sh	2026-06-29	—
STGWStagwell Inc	Grant — · 22,970 sh	2026-06-11	—
STGWStagwell Inc	Grant $20.0K · 4,090 sh	2026-01-02	—
STGWStagwell Inc	Grant $20.0K · 3,552 sh	2025-10-01	—
STGWStagwell Inc	Grant $20.0K · 4,444 sh	2025-07-01	—
STGWStagwell Inc	Grant — · 30,000 sh	2025-06-12	—

TBPHSell

2026-07-07 · Theravance Biopharma, Inc.

$95.5K

—

TBPHSell

2026-07-06 · Theravance Biopharma, Inc.

$23.9K

—

TBPHSell

2026-07-01 · Theravance Biopharma, Inc.

$642.6K

—

TBPHSell

2026-06-30 · Theravance Biopharma, Inc.

$428.8K

—

TBPHSell

2026-06-29 · Theravance Biopharma, Inc.

$4.72M

—

STGWGrant

2026-06-11 · Stagwell Inc

22,970

—

STGWGrant

2026-01-02 · Stagwell Inc

$20.0K

—

STGWGrant

2025-10-01 · Stagwell Inc

$20.0K

—

STGWGrant

2025-07-01 · Stagwell Inc

$20.0K

—

STGWGrant

2025-06-12 · Stagwell Inc

30,000

—

Newest 10 of 12 filingsEvery Form 4 on record, with outcomesPro →

Outcomes measure each position — the first buy in a stock and every buy within 182 days — against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.